HistoSonics is shopping for a potential buyer of its approach to destroying liver tumors with focused sound waves, according ...

HCC occurred in 1.27% of patients with PBC, which is lower than the recommended threshold for cost-effective surveillance.

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Symptoms, and Treatment Liver cancer is one of the most challenging forms of cancer, often developing quietly before showing any clear signs. It begins when abnormal cells form in the liver, a vital ...

HistoSonics today announced 12-month follow-up clinical data from its prospective HOPE4LIVER trials evaluating its ...

Tempest Therapeutics is hunkering down to weather the storm that has engulfed its operations. | Tempest Therapeutics is ...

Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

HistoSonics, developer of the Edison histotripsy system, announced 12-month follow-up clinical data from its prospective #HOPE4LI ...

HistoSonics, the developer of the Edison Histotripsy System, announced today 12-month follow-up clinical data from its prospective #HOPE4LIVER trials, designed to evaluate the safety and efficacy of ...

During a Community Case Forum event, Stacey Stein, MD, discussed data guiding the use of current regimens for the treatment ...